Anne Moscona - Publications

Affiliations: 
Icahn School of Medicine at Mount Sinai, New York, NY, United States 
Area:
Microbiology Biology

92 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Outlaw VK, Cheloha RW, Jurgens EM, Bovier FT, Zhu Y, Kreitler DF, Harder O, Niewiesk S, Porotto M, Gellman SH, Moscona A. Engineering Protease-Resistant Peptides to Inhibit Human Parainfluenza Viral Respiratory Infection. Journal of the American Chemical Society. PMID 33825470 DOI: 10.1021/jacs.1c01565  0.32
2021 Rodrigues Toste de Carvalho AL, Liu HY, Chen YW, Porotto M, Moscona A, Snoeck HW. The in vitro multilineage differentiation and maturation of lung and airway cells from human pluripotent stem cell-derived lung progenitors in 3D. Nature Protocols. PMID 33649566 DOI: 10.1038/s41596-020-00476-z  0.32
2021 de Vries RD, Schmitz KS, Bovier FT, Predella C, Khao J, Noack D, Haagmans BL, Herfst S, Stearns KN, Drew-Bear J, Biswas S, Rockx B, McGill G, Dorrello NV, Gellman SH, ... ... Moscona A, et al. Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets. Science (New York, N.Y.). PMID 33597220 DOI: 10.1126/science.abf4896  0.32
2020 de Vries RD, Schmitz KS, Bovier FT, Noack D, Haagmans BL, Biswas S, Rockx B, Gellman SH, Alabi CA, de Swart RL, Moscona A, Porotto M. Intranasal fusion inhibitory lipopeptide prevents direct contact SARS-CoV-2 transmission in ferrets. Biorxiv : the Preprint Server For Biology. PMID 33173865 DOI: 10.1101/2020.11.04.361154  0.32
2020 Weisberg SP, Connors TJ, Zhu Y, Baldwin MR, Lin WH, Wontakal S, Szabo PA, Wells SB, Dogra P, Gray J, Idzikowski E, Stelitano D, Bovier FT, Davis-Porada J, Matsumoto R, ... ... Moscona A, et al. Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum. Nature Immunology. PMID 33154590 DOI: 10.1038/s41590-020-00826-9  0.32
2020 Outlaw VK, Bovier FT, Mears MC, Cajimat MN, Zhu Y, Lin MJ, Addetia A, Lieberman NAP, Peddu V, Xie X, Shi PY, Greninger AL, Gellman SH, Bente DA, Moscona A, et al. Inhibition of Coronavirus Entry and by a Lipid-Conjugated Peptide Derived from the SARS-CoV-2 Spike Glycoprotein HRC Domain. Mbio. 11. PMID 33082259 DOI: 10.1128/mBio.01935-20  0.32
2020 Marcink TC, Wang T, des Georges A, Porotto M, Moscona A. Human parainfluenza virus fusion complex glycoproteins imaged in action on authentic viral surfaces. Plos Pathogens. 16: e1008883. PMID 32956394 DOI: 10.1371/Journal.Ppat.1008883  0.32
2020 Lieberman NAP, Peddu V, Xie H, Shrestha L, Huang ML, Mears MC, Cajimat MN, Bente DA, Shi PY, Bovier F, Roychoudhury P, Jerome KR, Moscona A, Porotto M, Greninger AL. In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age. Plos Biology. 18: e3000849. PMID 32898168 DOI: 10.1371/Journal.Pbio.3000849  0.32
2020 Weisberg SP, Connors T, Zhu Y, Baldwin M, Lin WH, Wontakal S, Szabo PA, Wells SB, Dogra P, Gray JI, Idzikowski E, Bovier F, Davis-Porada J, Matsumoto R, Li Poon MM, ... ... Moscona A, et al. Antibody responses to SARS-CoV2 are distinct in children with MIS-C compared to adults with COVID-19. Medrxiv : the Preprint Server For Health Sciences. PMID 32699861 DOI: 10.1101/2020.07.12.20151068  0.32
2020 Outlaw VK, Kreitler DF, Stelitano D, Porotto M, Moscona A, Gellman SH. Effects of single α-to-β residue replacements on recognition of an extended segment in a viral fusion protein. Acs Infectious Diseases. PMID 32692914 DOI: 10.1021/Acsinfecdis.0C00385  0.32
2020 Lieberman NAP, Peddu V, Xie H, Shrestha L, Huang ML, Mears MC, Cajimat MN, Bente DA, Shi PY, Bovier F, Roychoudhury P, Jerome KR, Moscona A, Porotto M, Greninger AL. antiviral host response to SARS-CoV-2 by viral load, sex, and age. Biorxiv : the Preprint Server For Biology. PMID 32607510 DOI: 10.1101/2020.06.22.165225  0.32
2020 Outlaw VK, Lemke JT, Zhu Y, Gellman SH, Porotto M, Moscona A. Structure-Guided Improvement of a Dual HPIV3/RSV Fusion Inhibitor. Journal of the American Chemical Society. PMID 31951396 DOI: 10.2210/Pdb6O40/Pdb  0.32
2019 Mendonça DA, Figueira TN, Melo MN, Harder O, Niewiesk S, Moscona A, Porotto M, Veiga AS. Self-assembly Stability Compromises the Efficacy of Tryptophan-Containing Designed Anti-measles Virus Peptides. Journal of Nanomedicine & Nanotechnology. 10. PMID 31572621 DOI: 10.35248/2157-7439.19.10.528  0.32
2019 Outlaw VK, Bottom-Tanzer S, Kreitler DF, Gellman SH, Porotto M, Moscona A. Dual Inhibition of Human Parainfluenza Type 3 and Respiratory Syncytial Virus Infectivity with a Single Agent. Journal of the American Chemical Society. PMID 31268705 DOI: 10.2210/Pdb6Nyx/Pdb  0.32
2019 Porotto M, Ferren M, Chen YW, Siu Y, Makhsous N, Rima B, Briese T, Greninger AL, Snoeck HW, Moscona A. Authentic Modeling of Human Respiratory Virus Infection in Human Pluripotent Stem Cell-Derived Lung Organoids. Mbio. 10. PMID 31064833 DOI: 10.1128/Mbio.00723-19  0.32
2019 Mathieu C, Ferren M, Jurgens E, Dumont C, Rybkina K, Harder O, Stelitano D, Madeddu S, Sanna G, Schwartz D, Biswas S, Hardie D, Hashiguchi T, Moscona A, Horvat B, et al. Measles virus bearing MIBE-derived fusion protein is pathogenic after infection via the respiratory route. Journal of Virology. PMID 30728259 DOI: 10.1128/Jvi.01862-18  0.32
2018 Angius F, Smuts H, Rybkina K, Stelitano D, Eley B, Wilmshurst J, Ferren M, Lalande A, Mathieu C, Moscona A, Horvat B, Hashiguchi T, Porotto M, Hardie D. Analysis of a subacute sclerosing panencephalitis (SSPE) Genotype B3 virus from the 2009/10 South African measles epidemic shows hyperfusogenic F proteins contribute to measles virus infection in the brain. Journal of Virology. PMID 30487282 DOI: 10.1128/Jvi.01700-18  0.32
2018 Figueira TN, Mendonça DA, Gaspar D, Melo MN, Moscona A, Porotto M, Castanho MARB, Veiga AS. Structure-Stability-Function Mechanistic Links in the Anti-Measles Virus Action of Tocopherol-Derivatized Peptide Nanoparticles. Acs Nano. PMID 30230818 DOI: 10.1021/Acsnano.8B01422  0.32
2018 Figueira TN, Augusto MT, Rybkina K, Stelitano D, Noval MG, Harder OE, Veiga AS, Huey D, Alabi CA, Biswas S, Niewiesk S, Moscona A, Santos NC, Castanho MARB, Porotto M. Effective in vivo targeting of influenza virus through a cell-penetrating/fusion inhibitor tandem peptide anchored to plasma membrane. Bioconjugate Chemistry. PMID 30169965 DOI: 10.1021/Acs.Bioconjchem.8B00527  0.32
2018 Iketani S, Shean RC, Ferren M, Makhsous N, Aquino DB, des Georges A, Rima B, Mathieu C, Porotto M, Moscona A, Greninger AL. Viral Entry Properties Required for Fitness in Humans Are Lost through Rapid Genomic Change during Viral Isolation. Mbio. 9. PMID 29970463 DOI: 10.1128/Mbio.00898-18  0.32
2018 Mathieu C, Porotto M, Figueira T, Horvat B, Moscona A. Fusion Inhibitory Lipopeptides Engineered for Prophylaxis of Nipah Virus in Primates. The Journal of Infectious Diseases. PMID 29566184 DOI: 10.1093/Infdis/Jiy152  0.32
2017 Augusto MT, Hollmann A, Porotto M, Moscona A, Santos NC. Antiviral Lipopeptide-Cell Membrane Interaction Is Influenced by PEG Linker Length. Molecules (Basel, Switzerland). 22. PMID 28714870 DOI: 10.3390/Molecules22071190  0.32
2017 Chen YW, Huang SX, de Carvalho ALRT, Ho SH, Islam MN, Volpi S, Notarangelo LD, Ciancanelli M, Casanova JL, Bhattacharya J, Liang AF, Palermo LM, Porotto M, Moscona A, Snoeck HW. A three-dimensional model of human lung development and disease from pluripotent stem cells. Nature Cell Biology. PMID 28436965 DOI: 10.1038/Ncb3510  0.32
2017 Figueira TN, Freire JM, Cunha-Santos C, Heras M, Gonçalves J, Moscona A, Porotto M, Salomé Veiga A, Castanho MA. Quantitative analysis of molecular partition towards lipid membranes using surface plasmon resonance. Scientific Reports. 7: 45647. PMID 28358389 DOI: 10.1038/Srep45647  0.32
2017 Mathieu C, Augusto MT, Niewiesk S, Horvat B, Palermo LM, Sanna G, Madeddu S, Huey D, Castanho MA, Porotto M, Santos NC, Moscona A. Broad spectrum antiviral activity for paramyxoviruses is modulated by biophysical properties of fusion inhibitory peptides. Scientific Reports. 7: 43610. PMID 28344321 DOI: 10.1038/Srep43610  0.32
2016 Palermo LM, Uppal M, Skrabanek L, Zumbo P, Germer S, Toussaint NC, Rima BK, Huey D, Niewiesk S, Porotto M, Moscona A. Features of Circulating Parainfluenza Virus Required for Growth in Human Airway. Mbio. 7. PMID 26980833 DOI: 10.1128/Mbio.00235-16  0.32
2016 Gui L, Jurgens E, Ebner JL, Porotto M, Moscona A, Lee KK. Erratum for Gui et al., Electron Tomography Imaging of Surface Glycoproteins on Human Parainfluenza Virus 3: Association of Receptor Binding and Fusion Proteins before Receptor Engagement. Mbio. 7. PMID 26787830 DOI: 10.1128/Mbio.01928-15  0.32
2015 Gui L, Jurgens EM, Ebner JL, Porotto M, Moscona A, Lee KK. Electron tomography imaging of surface glycoproteins on human parainfluenza virus 3: association of receptor binding and fusion proteins before receptor engagement. Mbio. 6: e02393-14. PMID 25691596 DOI: 10.1128/Mbio.02393-14  0.32
2015 Jurgens EM, Mathieu C, Palermo LM, Hardie D, Horvat B, Moscona A, Porotto M. Measles fusion machinery is dysregulated in neuropathogenic variants. Mbio. 6. PMID 25670774 DOI: 10.1128/Mbio.02528-14  0.32
2015 Palgen JL, Jurgens EM, Moscona A, Porotto M, Palermo LM. Unity in diversity: shared mechanism of entry among paramyxoviruses. Progress in Molecular Biology and Translational Science. 129: 1-32. PMID 25595799 DOI: 10.1016/Bs.Pmbts.2014.10.001  0.32
2015 Gui L, Jurgens EM, Ebner JL, Porotto M, Moscona A, Lee KK. Electron tomography imaging of surface glycoproteins on human parainfluenza virus 3: Association of receptor binding and fusion proteins before receptor engagement Mbio. 6. DOI: 10.1128/mBio.02393-14  0.32
2015 Moscona A. RSV vaccine: Beating the virus at its own game Science Translational Medicine. 7. DOI: 10.1126/scitranslmed.aad2515  0.32
2015 Palgen JL, Jurgens EM, Moscona A, Porotto M, Palermo LM. Unity in diversity: Shared mechanism of entry among paramyxoviruses Progress in Molecular Biology and Translational Science. 129: 1-32. DOI: 10.1016/bs.pmbts.2014.10.001  0.32
2014 Palmer SG, DeVito I, Jenkins SG, Niewiesk S, Porotto M, Moscona A. Circulating clinical strains of human parainfluenza virus reveal viral entry requirements for in vivo infection. Journal of Virology. 88: 13495-502. PMID 25210187 DOI: 10.1128/Jvi.01965-14  0.32
2014 Palmer SG, DeVito I, Jenkins SG, Niewiesk S, Porotto M, Moscona A. Circulating clinical strains of human parainfluenza virus reveal viral entry requirements for in vivo infection Journal of Virology. 88: 13495-13502. DOI: 10.1128/JVI.01965-14  0.32
2014 Englund JA, Moscona A. Paramyxoviruses: Parainfluenza Viruses Viral Infections of Humans: Epidemiology and Control. 579-600. DOI: 10.1007/978-1-4899-7448-8_25  0.32
2013 Xu R, Palmer SG, Porotto M, Palermo LM, Niewiesk S, Wilson IA, Moscona A. Interaction between the hemagglutinin-neuraminidase and fusion glycoproteins of human parainfluenza virus type III regulates viral growth in vivo. Mbio. 4: e00803-13. PMID 24149514 DOI: 10.1128/Mbio.00803-13  0.32
2013 Welsch JC, Talekar A, Mathieu C, Pessi A, Moscona A, Horvat B, Porotto M. Fatal measles virus infection prevented by brain-penetrant fusion inhibitors Journal of Virology. 87: 13785-13794. PMID 24109233 DOI: 10.1128/Jvi.02436-13  0.32
2013 Talekar A, Moscona A, Porotto M. Measles virus fusion machinery activated by sialic acid binding globular domain Journal of Virology. 87: 13619-13627. PMID 24109225 DOI: 10.1128/Jvi.02256-13  0.32
2013 Talekar A, DeVito I, Salah Z, Palmer SG, Chattopadhyay A, Rose JK, Xu R, Wilson IA, Moscona A, Porotto M. Identification of a region in the stalk domain of the nipah virus receptor binding protein that is critical for fusion activation. Journal of Virology. 87: 10980-96. PMID 23903846 DOI: 10.1128/Jvi.01646-13  0.32
2012 Porotto M, Salah ZW, Gui L, DeVito I, Jurgens EM, Lu H, Yokoyama CC, Palermo LM, Lee KK, Moscona A. Regulation of paramyxovirus fusion activation, the hemagglutinin-neuraminidase protein stabilizes the fusion protein in a pretriggered state Journal of Virology. 86: 12838-12848. PMID 22993149 DOI: 10.1128/Jvi.01965-12  0.32
2012 Palmer SG, Porotto M, Palermo LM, Cunha LF, Greengard O, Moscona A. Adaptation of human parainfluenza virus to airway epithelium reveals fusion properties required for growth in host tissue Mbio. 3. PMID 22669629 DOI: 10.1128/Mbio.00137-12  0.32
2012 Pessi A, Langella A, Capitò E, Ghezzi S, Vicenzi E, Poli G, Ketas T, Mathieu C, Cortese R, Horvat B, Moscona A, Porotto M. A general strategy to endow natural fusion-protein-derived peptides with potent antiviral activity Plos One. 7. PMID 22666328 DOI: 10.1371/Journal.Pone.0036833  0.32
2012 DeLaMora P, Moscona A. Bronchiolitis: Too-familiar yet too-mysterious disease of childhood Archives of Pediatrics and Adolescent Medicine. 166: 769-770. PMID 22473888 DOI: 10.1001/Archpediatrics.2012.157  0.32
2012 Porotto M, Salah Z, DeVito I, Talekar A, Palmer SG, Xu R, Wilson IA, Moscona A. The second receptor binding site of the globular head of the newcastle disease virus hemagglutinin-neuraminidase activates the stalk of multiple paramyxovirus receptor binding proteins to trigger fusion Journal of Virology. 86: 5730-5741. PMID 22438532 DOI: 10.1128/Jvi.06793-11  0.32
2012 Talekar A, Pessi A, Glickman F, Sengupta U, Briese T, Whitt MA, Mathieu C, Horvat B, Moscona A, Porotto M. Rapid screening for entry inhibitors of highly pathogenic viruses under low-level biocontainment Plos One. 7. PMID 22396728 DOI: 10.1371/Journal.Pone.0030538  0.32
2012 Porotto M, Palmer SG, Palermo LM, Moscona A. Mechanism of fusion triggering by human parainfluenza virus type III: Communication between viral glycoproteins during entry Journal of Biological Chemistry. 287: 778-793. PMID 22110138 DOI: 10.1074/Jbc.M111.298059  0.32
2011 Lee KK, Pessi A, Gui L, Santoprete A, Talekar A, Moscona A, Porotto M. Capturing a fusion intermediate of influenza hemagglutinin with a cholesterol-conjugated peptide, a new antiviral strategy for influenza virus Journal of Biological Chemistry. 286: 42141-42149. PMID 21994935 DOI: 10.1074/Jbc.M111.254243  0.32
2011 Porotto M, Devito I, Palmer SG, Jurgens EM, Yee JL, Yokoyama CC, Pessi A, Moscona A. Spring-loaded model revisited: paramyxovirus fusion requires engagement of a receptor binding protein beyond initial triggering of the fusion protein. Journal of Virology. 85: 12867-80. PMID 21976650 DOI: 10.1128/Jvi.05873-11  0.32
2011 Farzan SF, Palermo LM, Yokoyama CC, Orefice G, Fornabaio M, Sarkar A, Kellogg GE, Greengard O, Porotto M, Moscona A. Premature activation of the paramyxovirus fusion protein before target cell attachment with corruption of the viral fusion machinery Journal of Biological Chemistry. 286: 37945-37954. PMID 21799008 DOI: 10.1074/Jbc.M111.256248  0.32
2011 Porotto M, Yi F, Moscona A, LaVan DA. Synthetic protocells interact with viral nanomachinery and inactivate pathogenic human virus. Plos One. 6: e16874. PMID 21390296 DOI: 10.1371/Journal.Pone.0016874  0.32
2010 Porotto M, Rockx B, Yokoyama CC, Talekar A, DeVito I, Palermo LM, Liu J, Cortese R, Lu M, Feldmann H, Pessi A, Moscona A. Inhibition of Nipah Virus Infection In Vivo: Targeting an early stage of paramyxovirus fusion activation during viral entry Plos Pathogens. 6. PMID 21060819 DOI: 10.1371/Journal.Ppat.1001168  0.32
2010 Moscona A, Porotto M, Palmer S, Tai C, Aschenbrenner L, Triana-Baltzer G, Li QX, Wurtman D, Niewiesk S, Fang F. A recombinant sialidase fusion protein effectively inhibits human parainfluenza viral infection in vitro and in vivo Journal of Infectious Diseases. 202: 234-241. PMID 20533871 DOI: 10.1086/653621  0.32
2010 Porotto M, Yokoyama CC, Palermo LM, Mungall B, Aljofan M, Cortese R, Pessi A, Moscona A. Viral entry inhibitors targeted to the membrane site of action Journal of Virology. 84: 6760-6768. PMID 20357085 DOI: 10.1128/Jvi.00135-10  0.32
2010 Wolf MC, Freiberg AN, Zhang T, Akyol-Ataman Z, Grock A, Hong PW, Li J, Watson NF, Fang AQ, Aguilar HC, Porotto M, Honko AN, Damoiseaux R, Miller JP, Woodson SE, ... ... Moscona A, et al. A broad-spectrum antiviral targeting entry of enveloped viruses. Proceedings of the National Academy of Sciences of the United States of America. 107: 3157-62. PMID 20133606 DOI: 10.1073/Pnas.0909587107  0.32
2009 Aljofan M, Sganga ML, Lo MK, Rootes CL, Porotto M, Meyer AG, Saubern S, Moscona A, Mungall BA. Antiviral activity of gliotoxin, gentian violet and brilliant green against Nipah and Hendra virus in vitro Virology Journal. 6. PMID 19889218 DOI: 10.1186/1743-422X-6-187  0.32
2009 Palermo LM, Porotto M, Yokoyama CC, Palmer SG, Mungall BA, Greengard O, Niewiesk S, Moscona A. Human parainfluenza virus infection of the airway epithelium: Viral hemagglutinin-neuraminidase regulates fusion protein activation and modulates infectivity Journal of Virology. 83: 6900-6908. PMID 19386708 DOI: 10.1128/Jvi.00475-09  0.32
2009 Porotto M, Yokoyama CC, Orefice G, Kim HS, Aljofan M, Mungall BA, Moscona A. Kinetic dependence of paramyxovirus entry inhibition Journal of Virology. 83: 6947-6951. PMID 19369345 DOI: 10.1128/Jvi.00416-09  0.32
2009 Porotto M, Orefice G, Yokoyama CC, Mungall BA, Realubit R, Sganga ML, Aljofan M, Whitt M, Glickman F, Moscona A. Simulating henipavirus multicycle replication in a screening assay leads to identification of a promising candidate for therapy Journal of Virology. 83: 5148-5155. PMID 19264786 DOI: 10.1128/Jvi.00164-09  0.32
2009 Moscona A. Global transmission of oseltamivir-resistant influenza New England Journal of Medicine. 360: 953-956. DOI: 10.1056/NEJMp0900648  0.32
2008 Peters PH, Moscona A, Schulman KL, Barr CE. Study of the impact of oseltamivir on the risk for pneumonia and other outcomes of influenza, 2000-2005. Medscape Journal of Medicine. 10: 131. PMID 18679536  0.32
2008 Aljofan M, Porotto M, Moscona A, Mungall BA. Development and validation of a chemiluminescent immunodetection assay amenable to high throughput screening of antiviral drugs for Nipah and Hendra virus Journal of Virological Methods. 149: 12-19. PMID 18313148 DOI: 10.1016/J.Jviromet.2008.01.016  0.32
2008 Moscona A. Medical management of influenza infection Annual Review of Medicine. 59: 397-413. PMID 17939760 DOI: 10.1146/Annurev.Med.59.061506.213121  0.32
2007 Moscona A. CSI microbiology: Emerging pathogens and a staged strategy for detection and discovery Journal of Infectious Diseases. 196: 1727-1728. PMID 18190250 DOI: 10.1086/524313  0.32
2007 Palermo LM, Porotto M, Greengard O, Moscona A. Fusion promotion by a paramyxovirus hemagglutinin-neuraminidase protein: pH modulation of receptor avidity of binding sites I and II Journal of Virology. 81: 9152-9161. PMID 17567695 DOI: 10.1128/Jvi.00888-07  0.32
2007 Moscona A, McKimm-Breschkin J. News about influenza B drug resistance that cannot be ignored Journal of the American Medical Association. 297: 1492-1493. PMID 17405975 DOI: 10.1001/Jama.297.13.1492  0.32
2007 DeLaMora P, Moscona A. A daring treatment and a successful outcome: The need for targeted therapies for pediatric respiratory viruses Pediatric Transplantation. 11: 121-123. PMID 17300487 DOI: 10.1111/J.1399-3046.2006.00654.X  0.32
2007 Porotto M, Fornabaio M, Kellogg GE, Moscona A. A second receptor binding site on human parainfluenza virus type 3 hemagglutinin-neuraminidase contributes to activation of the fusion mechanism Journal of Virology. 81: 3216-3228. PMID 17229690 DOI: 10.1128/Jvi.02617-06  0.32
2006 Loughlin GM, Moscona A. The cell biology of acute childhood respiratory disease: therapeutic implications. Pediatric Clinics of North America. 53: 929-59, ix-x. PMID 17027618 DOI: 10.1016/J.Pcl.2006.08.004  0.32
2006 Porotto M, Fornabaio M, Greengard O, Murrell MT, Kellogg GE, Moscona A. Paramyxovirus receptor-binding molecules: Engagement of one site on the hemagglutinin-neuraminidase protein modulates activity at the second site Journal of Virology. 80: 1204-1213. PMID 16414997 DOI: 10.1128/Jvi.80.3.1204-1213.2006  0.32
2005 Moscona A. Oseltamivir resistance - Disabling our influenza defenses New England Journal of Medicine. 353: 2633-2636. PMID 16371626 DOI: 10.1056/Nejmp058291  0.32
2005 Moscona A. Neuraminidase inhibitors for influenza New England Journal of Medicine. 353: 1363-1373. PMID 16192481 DOI: 10.1056/Nejmra050740  0.32
2005 Moscona A. Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease Journal of Clinical Investigation. 115: 1688-1698. PMID 16007245 DOI: 10.1172/Jci25669  0.32
2005 Porotto M, Murrell M, Greengard O, Doctor L, Moscona A. Influence of the human parainfluenza virus 3 attachment protein's neuraminidase activity on its capacity to activate the fusion protein Journal of Virology. 79: 2383-2392. PMID 15681439 DOI: 10.1128/Jvi.79.4.2383-2392.2005  0.32
2004 Porotto M, Murrell M, Greengard O, Lawrence MC, McKimm-Breschkin JL, Moscona A. Inhibition of parainfluenza virus type 3 and newcastle disease virus hemagglutinin-neuraminidase receptor binding: Effect of receptor avidity and steric hindrance at the inhibitor binding sites Journal of Virology. 78: 13911-13919. PMID 15564499 DOI: 10.1128/Jvi.78.24.13911-13919.2004  0.32
2004 Moscona A. Oseltamivir-resistant influenza? Lancet. 364: 733-734. PMID 15337382 DOI: 10.1016/S0140-6736(04)16947-X  0.32
2003 Porotto M, Murrell M, Greengard O, Moscona A. Triggering of human parainfluenza virus 3 fusion protein (F) by the hemagglutinin-neuraminidase (HN) protein: An HN mutation diminishes the rate of F activation and fusion Journal of Virology. 77: 3647-3654. PMID 12610140 DOI: 10.1128/Jvi.77.6.3647-3654.2003  0.32
2003 Murrell M, Porotto M, Weber T, Greengard O, Moscona A. Mutations in human parainfluenza virus type 3 hemagglutinin-neuraminidase causing increased receptor binding activity and resistance to the transition state sialic acid analog 4-GU-DANA (Zanamivir) Journal of Virology. 77: 309-317. PMID 12477836 DOI: 10.1128/Jvi.77.1.309-317.2003  0.32
2001 Prince GA, Ottolini MG, Moscona A. Contribution of the human parainfluenza virus type 3 HN-receptor interaction to pathogenesis in vivo Journal of Virology. 75: 12446-12451. PMID 11711635 DOI: 10.1128/Jvi.75.24.12446-12451.2001  0.32
2001 Murrell MT, Porotto M, Greengard O, Poltoratskaia N, Moscona A. A single amino acid alteration in the human parainfluenza virus type 3 hemagglutinin-neuraminidase glycoprotein confers resistance to the inhibitory effects of zanamivir on receptor binding and neuraminidase activity Journal of Virology. 75: 6310-6320. PMID 11413297 DOI: 10.1128/Jvi.75.14.6310-6320.2001  0.32
2000 Burroughs M, Moscona A. Immunization of pediatric solid organ transplant candidates and recipients Clinical Infectious Diseases. 30: 857-869. PMID 10852737 DOI: 10.1086/313823  0.32
2000 Moscona A. Management of respiratory syncytial virus infections in the immunocompromised child Pediatric Infectious Disease Journal. 19: 253-254. PMID 10749471 DOI: 10.1097/00006454-200003000-00017  0.32
1997 Moscona A. Interaction of human parainfluenza virus type 3 with the host cell surface Pediatric Infectious Disease Journal. 16: 917-924. PMID 9380464 DOI: 10.1097/00006454-199710000-00003  0.32
1996 Moscona A, Peluso RW. Analysis of human parainfluenza virus 3 receptor binding variants: Evidence for the use of a specific sialic acid-containing receptor Microbial Pathogenesis. 20: 179-184. PMID 8965678 DOI: 10.1006/Mpat.1996.0016  0.32
1995 Huberman K, Peluso RW, Moscona A. Hemagglutinin-neuraminidase of human parainfluenza 3: Role of the neuraminidase in the viral life cycle Virology. 214: 294-300. PMID 8525632 DOI: 10.1006/Viro.1995.9925  0.32
1993 Moscona A, Peluso RW. Relative affinity of the human parainfluenza virus type 3 hemagglutinin- neuraminidase for sialic acid correlates with virus-induced fusion activity Journal of Virology. 67: 6463-6468. PMID 8411349 DOI: 10.1128/Jvi.67.11.6463-6468.1993  0.32
1993 Moscona A, Peluso RW. Persistent infection with human parainfluenza virus 3 in CV-1 cells: Analysis of the role of defective interfering particles Virology. 194: 399-402. PMID 8386885 DOI: 10.1006/Viro.1993.1275  0.32
1992 Moscona A, Peluso RW. Fusion properties of cells infected with human parainfluenza virus type 3: Receptor requirements for viral spread and virus-mediated membrane fusion Journal of Virology. 66: 6280-6287. PMID 1328668 DOI: 10.1128/Jvi.66.11.6280-6287.1992  0.32
1991 Moscona A, Peluso RW. Fusion properties of cells persistently infected with human parainfluenza virus type 3: Participation of hemagglutinin-neuraminidase in membrane fusion Journal of Virology. 65: 2773-2777. PMID 1851852 DOI: 10.1128/Jvi.65.6.2773-2777.1991  0.32
1991 Moscona A. Defective interfering particles of human parainfluenza virus type 3 are associated with persistent infection in cell culture Virology. 183: 821-824. PMID 1649512 DOI: 10.1016/0042-6822(91)91018-C  0.32
1991 Moscona A, Peluso RW. Properties of human parainfluenza virus type 3 RNA polymerase/replicase activity in vitro: Consensus with other negative-stranded RNA viruses Journal of Virology. 65: 4470-4474. PMID 1649342 DOI: 10.1128/Jvi.65.8.4470-4474.1991  0.32
1990 Moscona A, Galinski MS. Characterization of human parainfluenza virus type 3 persistent infection in cell culture Journal of Virology. 64: 3212-3218. PMID 2161938 DOI: 10.1128/Jvi.64.7.3212-3218.1990  0.32
Show low-probability matches.